Item description | Packaging | Case qty | Item code |
---|---|---|---|
Irinotecan 40mg/2ml concentrate for solution for infusion | 2ml vial | 1 | 9480002830 |
Irinotecan 100mg/5ml concentrate for solution for infusion | 5ml vial | 1 | 9480002831 |
Irinotecan 300mg/15ml concentrate for solution for infusion | 15ml vial | 1 | 9480002832 |
Irinotecan 500mg/25ml concentrate for solution for infusion | 25ml vial | 1 | 9480002833 |
Irinotecan
Concentrate for solution for infusion
Details
- Product info
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited. Email: Pharmacovigilance.GB@fresenius-kabi.com
GB-Onco-2400003 December 2024